MENU
Advertisement
Table of Contents
Supplement
September 2017 Supplement
Evidence From the Next-Generation DCB
Delivering top-tier clinical outcomes.
Sponsored by Spectranetics Corporation
Issue
SFA
The Forces Driving Care
View Issue
Comparative Analysis of Drug-Coated Balloons
By Juan F. Granada, MD, FACC
The Stellarex Difference: Critical Components of an Optimal DCB
By Manasi Ramachandran, PhD, and Michael S. Owens, PhD
The ILLUMENATE SFA Clinical Program
Data on the Stellarex DCB for treatment of femoropopliteal arterial disease.
By Henrik Schröder, MD; and Prakash Krishnan, MD
Vessel Preparation With Laser Atherectomy and Scoring Balloon Angioplasty Before Drug-Coated Balloon Angioplasty
By Ehrin J. Armstrong, MD
Improving PAD Awareness, Access, and Amputation Prevention
With Eric A. Secemsky, MD, MSc, RPVI, FACC, FAHA, FSCAI, FSVM
Expanding Neurovascular Applications of the Swift™ Coil System
With Mohsen Nouri, MD; Robert M. Starke, MD; Allison E. Strickland, MD; and Nitin Goyal, MD
SEISMIQ™ IVL System as a Next-Generation Technology Offering for Complex PAD
With Jaafer Golzar, MD, FACC, FSCAI, and Gregory A. Stanley, MD, FACS
The 2026 AHA/ACC Guideline for the Management of Acute Pulmonary Embolism
By Geoffrey D. Barnes, MD, MSc; Allison Burnett, PharmD; Jay Giri, MD, MPH; and Soophia Naydenov, MD
Simplifying PE Treatment: Real-World Experience With the AVENTUS® Thrombectomy System
With Austin Bourgeois, MD; Thomas Wong, MD; Ripal T. Gandhi, MD, FSVM, FSIR; and Patrick Muck, MD
Latest Issues
September 2026
August 2026
July 2026
June 2026
May 2026
View All Issues